Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects.
暂无分享,去创建一个
S. Pede | G. Ambrosio | G. Reboldi | G. Schillaci | P. Verdecchia | F. Angeli | C. Porcellati | M. Bentivoglio | Silvia Norgiolini
[1] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[2] Daniel Duprez,et al. The prognostic value of ambulatory blood pressure in treated hypertension: the office versus ambulatory (OvA) blood pressure study , 2002 .
[3] J. Schwartz,et al. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. , 2001, Journal of the American College of Cardiology.
[4] G Parati,et al. Ambulatory Blood Pressure Monitoring and Organ Damage , 2000, Hypertension.
[5] P. Verdecchia,et al. Prognostic value of ambulatory blood pressure : current evidence and clinical implications. , 2000, Hypertension.
[6] M Ishii,et al. [The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, and 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.
[7] E. Sandoya,et al. Ambulatory Blood Pressure , 1999 .
[8] L. Poston,et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society , 1999, Journal of Human Hypertension.
[9] Gianfranco Parati,et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. , 1999 .
[10] H. Ward,et al. Inadequate management of blood pressure in a hypertensive population. , 1999, New England Journal of Medicine.
[11] R. Senior,et al. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. , 1998, Circulation.
[12] T. Kigoshi,et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. , 1998, Diabetes.
[13] J. Kimura,et al. Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. , 1998, Stroke.
[14] G. Schillaci,et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. , 1998, Journal of the American College of Cardiology.
[15] L. Ruilope,et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. , 1998, Hypertension.
[16] E. O’Brien,et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. , 1997, JAMA.
[17] T. Ohkubo,et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama , 1997, Journal of hypertension.
[18] Roberto Sega,et al. Blood-pressure control in the hypertensive population , 1997, The Lancet.
[19] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[20] G. Parati,et al. Difference between office and ambulatory blood pressure and response to antihypertensive treatment , 1996, Journal of hypertension.
[21] T. Pickering,et al. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. , 1996, American journal of hypertension.
[22] P Whelton,et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.
[23] G. Reboldi,et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.
[24] G. Schillaci,et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. , 1994, The American journal of cardiology.
[25] John Urquhart,et al. Role of Patient Compliance in Clinical Pharmacokinetics , 1994 .
[26] J. Swales. Guidelines for management of hypertension , 1994 .
[27] W. Klein,et al. "Non-dipping" related to cardiovascular events in essential hypertensive patients. , 1994, Acta medica Austriaca.
[28] J Urquhart,et al. Role of patient compliance in clinical pharmacokinetics. A review of recent research. , 1994, Clinical pharmacokinetics.
[29] C. Bulpitt,et al. Reference values for ambulatory blood pressure: a population study. , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[30] G. Schillaci,et al. Quantitative assessment of day-to-day spontaneous variability in non-invasive ambulatory blood pressure measurements in essential hypertension. , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[32] R. Newson,et al. Treated blood pressure, rather than pretreatment, predicts survival in hypertensive patients. A report from the DHSS Hypertension Care Computing Project (DHCCP). , 1988, Journal of hypertension.
[33] J. Clarke,et al. Mortality in patients of the Glasgow Blood Pressure Clinic. , 1986, Journal of hypertension.
[34] M. Sokolow,et al. The prognostic value of ambulatory blood pressures. , 1983, JAMA.
[35] Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.
[36] Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. , 1979, Diabetes.
[37] W. Kannel. Role of blood pressure in cardiovascular morbidity and mortality. , 1974, Progress in cardiovascular diseases.
[38] J. Robertson,et al. Some Aspects of Prognosis in Treated Hypertension , 1959, British medical journal.
[39] D.,et al. Regression Models and Life-Tables , 2022 .